Mesenchymal Stem Cells for Multiple Sclerosis
NCT01730547 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2023-06-01
Summary
The aim of the study is to evaluate the safety and efficacy of autologous mesenchymal stromal cells as treatment for Multiple Sclerosis.
Conditions
Interventions
- BIOLOGICAL
-
Autologous mesenchymal stem cells
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-02-28
- Primary Completion
- 2019-05-09
- Completion
- 2021-11-20
Countries
- Sweden
Study Locations
More Related Trials
-
Stem Cells in Rapidly Evolving Active Multiple Sclerosis
NCT01606215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis
NCT06592703 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis
NCT02035514 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)
NCT00395200 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis
NCT04749667 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis
NCT01933802 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis
NCT02166021 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis
NCT02034188 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Expanded Access to Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis
NCT03822858 ·Status: AVAILABLE
-
MEsenchymal StEm Cells for Multiple Sclerosis
NCT02403947 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
NCT01377870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis
NCT04823000 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study
NCT00273364 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis
NCT01895439 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis
NCT01056471 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis
NCT03355365 ·Status: COMPLETED ·Phase: PHASE2
-
Outcomes Data of Adipose Stem Cells to Treat Multiple Sclerosis
NCT02157064 ·Status: UNKNOWN
-
Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS
NCT00813969 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Intravenous Autologous Mesenchymal Stem Cells for MS: a Phase 2 Proof of Concept Study
NCT02239393 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Mesenchymal Stromal Cells for Multiple Sclerosis
NCT02495766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis
NCT05116540 ·Status: COMPLETED ·Phase: PHASE2
-
Mesenchymal Stem Cell Transplantation in MS
NCT01228266 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
NCT05532943 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
NCT06735248 ·Status: RECRUITING ·Phase: PHASE2
-
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
NCT03069170 ·Status: UNKNOWN ·Phase: PHASE1